Uploaded November 2026 | Updated November 2026, 4 hours ago
Steven Nathan, MD, MBBCh, FCCP, Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital, discusses findings from a post-hoc analysis of the phase 3 TETON-2 study, presented at the CHEST 2026 Annual Meeting.
View the full interview at checkrare.com/inhaled-treprostinil-reduces-multiple-disease-progression-events-in-ipf
Steven Nathan, MD, MBBCh, FCCP, Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital, discusses findings from a post-hoc analysis of the phase 3 TETON-2 study, presented at the CHEST 2026 Annual Meeting.
View the full interview at checkrare.com/inhaled-treprostinil-reduces-multiple-disease-progression-events-in-ipf










